Skip to main content
. 2014 Feb 18;55(4):761–768. doi: 10.1093/jrr/rrt235

Table 2.

Demographic and radiosurgical data of 14 patients with 56 lesions

Pt No. of lesions Machine Tech/no of lesions Dose (marg./max) (Gy) No of Fx. tumor volume ( cm3)
F/U (months)
Before treatment At last F/U
1 1 CK SRS/1 14/25 1 8.5 Cerebellum 17.16 cm3 Progression 11
2 8 CK SRS/8 11.5/19–21
13/18.5–21
14/19
1
1
1
0.027, 0.033, 0.058, 0.11
0.13, 0.25, 1.05
0.33
Cerebellum
PR 15
3 3 CK HSRT/3 21.25/28–32 5 0.048, 0.056, 0.895
Brainstem
SD 14
4 7 CK SRS/5
HSRT/2
20/25–30
24/28–23
1
3
0.026, 0.028, 0.051, 0.069, 0.109
Cerebellum
0.09, 0.14
Brainstem
SD 27
5 1 CK HSRT/1 22.5/25 5 20.4
Optic chiasm
SD 24
6 1 CK SRS/1 20/28 1 0.26
Cerebellum
SD 20
7 4 CK SRS/4 20/24 1 0.1, 0.19, 0.37, 0.58
Cerebellum
SD 12
8 6 CK HSRT/6 30/38
25/34–39
3
5
3.19, 4.6
Cerebellum
0.28, 0.31, 0.34, 0.87
Cerebellum
SD 12
9 1 CK HSRT/1 25/34 5 15.69
Optic chiasm
SD 14
10 7 CK SRS/4
HSRT/3
14/19–20
20/28
1
5
0.066, 0.144, 0.217, 0.28
Cerebellum
0.41, 0.71, 1.26
Brain stem
SD 24
11 5 linac SRS/5 10/13–17 1 0.2, 0.26, 1.14, 2.64, 6.08
Cerebellum
SD 42
12 10 Linac SRS/10 12/17
14/19
15/20
16/19
20/25
1 0.24, 0.57
0.04, 0.05, 0.06
0.08, 0.11
0.3
1.75, 3
Cerebellum
SD 89
13 1 Linac HSRT/1 30/41 10 2
Optic chiasm
SD 72
14 1 Linac HSRT/1 32/36 10 7.65
Brainstem
12.56 cm3 Progression 49

SRS = stereotactic radiosurgery, HSRT = hypofraction stereotactic radiotherapy, PR = partial response, SD = stable disease.